The current financial score of enVVeno Medical Corp is 5.44. Its financial status is weak, and its operating efficiency is low.
The current valuation score of enVVeno Medical Corp is 8.88. Its current P/E ratio is -0.01, which is -3.80% below the recent high of -0.01 and -136698.73% above the recent low of -10.81.
The current earnings forecast score of enVVeno Medical Corp is 10.00. The average price target is 30.00, with a high of 30.00 and a low of 30.00.
The current price momentum score of enVVeno Medical Corp is 5.93. Currently, the stock price is trading between the resistance level at 11.70 and the support level at 6.76, making it suitable for range-bound swing trading.
The current institutional shareholding score of enVVeno Medical Corp is 3.00. The latest institutional shareholding proportion is 27.61%, representing a quarter-over-quarter increase of 3.30%.
The current risk assessment score of enVVeno Medical Corp is 2.17. The company's beta value is 1.09. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.